Biosimilars have the potential to significantly reduce costs for medical centers, but the adoption rate is still very low. Fortunately, there are steps that pharmacists can take to increase use of these agents.
At the end of 2019, 17% of the biologics market were accessible to biosimilars, but there was only a 20% adoption rate, noted David Crosby, PharmD, BCOP, BCPS, the pharmacy director of system infusion at Dartmouth-Hitchcock Health, in Lebanon, N.H. Including approved but not